NPS PHARMACEUTICALS, INC. SEPARATION AND RELEASE OF CLAIMS AGREEMENTSeparation and Release of Claims Agreement • March 17th, 2008 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Utah
This Separation and Release of Claims Agreement ("Agreement") documents the agreement between you, Val Antczak, and NPS Pharmaceuticals, Inc., its subsidiaries and affiliates ("NPS") concerning the termination of your status as an employee of NPS effective December 7, 2007.
AMENDMENT NUMBER ONE TO AMENDING AGREEMENTAmending Agreement • March 17th, 2008 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)
WHEREAS, the Parties have entered into a COMMERCIAL MANUFACTURING AGREEMENT dated as of OCTOBER 18, 2002 (hereinafter, the "Agreement") for the manufacture of NPS ALLELIX proprietary product ALX-11 (also known as PREOS®), for which the active ingredient is recombinant human parathyroid hormone eighty-four (84) amino acids ("rhPTH"); and
ContractAgreement • March 17th, 2008 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)
NOTE: CERTAIN CONFIDENTIAL INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT AND REPLACED BY "[*]". A COMPLETE COPY OF THIS DOCUMENT INCLUDING THE CONFIDENTIAL INFORMATION HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
Asset Purchase Agreement by and between AstraZeneca AB, as Buyer, and NPS Pharmaceuticals, Inc., as SellerAsset Purchase Agreement • March 17th, 2008 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Asset Purchase Agreement (this "Agreement"), dated as of October 9, 2007, is by and between NPS Pharmaceuticals, Inc., a Delaware corporation ("Seller"), and AstraZeneca AB, a company limited by shares organized and existing under the laws of Sweden ("Buyer").
SEPARATION AND RELEASE OF CLAIMS AGREEMENTSeparation Agreement • March 17th, 2008 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New Jersey
This Separation and Release of Claims Agreement ("Agreement") documents the agreement between you, Gerard J. Michel, and NPS Pharmaceuticals, Inc., its subsidiaries and affiliates ("NPS" or "the Company") concerning the termination of your status as an employee of the Company effective the close of business on November 19, 2007.
